Table 5.
Discrepancies between the Alinity M RESP-4-Plex and the evaluated assay for SARS-CoV-2 (a), influenza A (b), and RSV (c).
| (a) | |||||||||||||
| Sample ID | Sex | Age |
Alinity M
(Ct) |
ID NOW COVID |
Idylla™
SARS-CoV-2 |
Idylla™ SARS-CoV2/Flu/RSV | Delay since Symptoms Onset | COVID-19 Vaccine | Symptoms | Oxygen Therapy | Outcome | ||
| Qualitative Result | Targets Ct | RNAseP (Ct) | |||||||||||
| 832301 | F | 21 | 31.2 | Negative | Positive | Negative | ORF1b a = nd N b = 44.3 N c = 44.3 |
34,5 | 3 | No | Abdominal pain | No | Discharge |
| 930001 | M | 46 | 31.8 | Negative | Negative | Negative | ORF1b a = nd N b = nd N c = nd |
34.3 | 14 | No | Flu-like syndrome | No | Discharge |
| 882501 | F | 31 | 32.3 | Negative | Positive | Negative | ORF1b a = nd N b = nd N c = nd |
35.3 | 5 | No | Flu-like syndrome | No | Discharge |
| 909701 | M | 29 | 33.9 | Negative | Positive | Negative | ORF1b a = nd N b = nd N c = 43.13 |
33.4 | 10 | n.a. | Headhache hypoaesthesia of the right side |
No | Discharge |
| 909301 | M | 22 | 36.4 | Negative | Positive | Negative | ORF1b a = nd N b = 41.15 N c = 43.29 |
30.2 | 14 | No | Flu-like syndrome | No | Discharge |
| (b) | |||||||||||||
| Sample ID | Sex | Age |
Alinity M
(Ct) |
ID NOW Indluenza A & B 2 | Idylla™ SARS-CoV2/Flu/RSV |
Delay since
Symptoms Onset |
Symptoms | Oxygen Therapy | Outcome | ||||
| Flu A (Ct) | RNAseP | ||||||||||||
| 501001 | M | 68 | 31 | Negative | Positive (39.7) | 33.6 | 7 | Dyspnea | 4 L | Hospitalization | |||
| 661701 | M | 39 | 36 | Negative | Negative | 33.6 | 1 | Flu-like syndrome | No | Discharge | |||
| (c) | |||||||||||||
| Sample ID | Sex | Age |
Alinity M
(Ct) |
Idylla™ SARS-CoV2/Flu/RSV |
Delay since
Symptoms Onset |
Symptoms | Oxygen Therapy | Outcome | |||||
| RSV | RNAseP E | ||||||||||||
| 842101 | F | 81 | 31 | Negative | 33.4 | n.a. | Dyspnea | 6 L | Hospitalization | ||||